Arena Lines Up $100 Million in Final Push for Obesity Drug |  |
|
Posted by Mary Canady June 17th, 2009 .
| |
| No Comments |
After reporting comprehensive findings from its major study of obesity drug lorcaserin 11 days ago, San Diego’s Arena Pharmaceuticals (NASDAQ: ARNA) said today it has arranged $100 million in...
[[Click headline to continue reading.]]
[[Click headline to continue reading.]]
See other entries categorized in News, Syndication, Xconomy.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
